Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
Cellectar Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Cellectar Biosciences reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, four executives at Cellectar Biosciences received on average a compensation package of $1.1M, a 89% increase compared to previous year.
Average pay of disclosed executives at Cellectar Biosciences
James V. Caruso, Chief Executive Officer, received $2.2M in total, which increased by 112% compared to 2020. 68% of Caruso's compensation, or $1.5M, was in option awards. Caruso also received $157K in non-equity incentive plan and $523K in salary.
Jarrod Longcor, Chief Operating Officer, received a compensation package of $891K, which increased by 55% compared to previous year. 46% of the compensation package, or $414K, was in option awards.
Dov Elefant, Chief Financial Officer, earned $838K in 2021, a 78% increase compared to previous year.
John E. Friend II, Chief Medical Officer, received $707K in 2021, which increases by 83% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 29, 2022.